Both obesity and vitamin D deficiency are linked to morbidity and ultimately mortality. Vitamin D sufficiency is believed to confer many health benefits; however, with the exception of the classic functions related to bone health these are not yet well understood, especially in relationship to pregnancy and infant health outcomes.
Furthermore, it has been reported that obese pregnant women have an increased use of healthcare services, especially for BMI >35, 19 increased caesarean section rate 20 and increased risk of infant mortality, both of which may involve cardiometabolic morbidity. 21 Catalano 22 suggests that this may be related to a decrease in insulin sensitivity, and therefore overweight and obese women are at increased risk of metabolic dysregulation in pregnancy, i.e. gestational diabetes, preeclampsia and foetal overgrowth.
The presence of vitamin D in sufficient quantities is thought to modify the risk of adverse cardiometabolic outcomes, 23, 24 although the association remains unclear. 25 Vitamin D is also thought to play an important role in insulin resistance and glucose homeostasis 26 and it has been proposed that vitamin D supplementation may be an effective addition to the standard treatment of obesity and its associated insulin resistance. 27 A couple of decades ago, four small studies 28 
Implications for Practice
Efforts to tackle the problems highlighted above have been hampered by the lack of high-quality evidence and thus it is difficult for clinicians to undertake any large-scale population or individual deficiency prevention programmes. 5, 37, 38 The scale of the problem for pregnant women is now becoming clearer, and there are an unacceptable number of women with vitamin D deficiency. 38 The report of Bodnar et al. 32 showed no difference between non-obese and obese individuals in the capacity of the skin to synthesise D3. However, the increase in blood vitamin D3 concentrations was 57 % less in the obese than in the non-obese subjects 24 hours after the exposure. Thus, obesity did not affect the capacity of the skin to produce vitamin D3, but may have altered the release of vitamin D3 from the skin into the circulation.
These data suggest that the availability of excessive adipose tissue causes a decrease in endogenously synthesised D3 to be released into circulation. Orally ingested vitamin D was more bioavailable and therefore suggests that vitamin D deficiency in obesity can be corrected by oral supplementation rather than using sunlamps.
The US National Institute for Health and the Endocrine Society 41 recommend that most people will be at optimum levels of vitamin D at 50 nmols/l and that in pregnancy the optimal daily recommended allowance is 600 IU or 15 mcg. In the UK this stands at 400 IU daily.
Consideration needs to be given as to how very deplete women, often the obese, will reach adequate levels. One study 31 
Conclusion
The discovery of vitamin D and the subsequent near elimination of rickets must rank as one of medicine's great achievements; 44 however, almost 100 years later, science is still grappling to understand and ascertain the implications of vitamin D deficiency. Therefore, it is difficult to make recommendations for health practitioners to follow when they
give advice about supplementation particularly during pregnancy. It is clear from inferences gained from the research to date that pregnant woman who are both obese and vitamin D deficient should not only be concerned about their own health but that of their offspring and that having sufficient vitamin D will improve their long term health outlook.
Interventions in this area, once more clearly understood, will improve intergenerational health and prenatal conditions, which are of vital importance, 22, 45 and surely this will involve further research, preconceptual care, and a population-wide public health intervention such as universal supplementation of vitamin D during pregnancy. n
